Markets:

Overview

News

Currencies

International

Treasuries

Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

2.235 -0.015 (-0.67%)

Streaming Delayed Price Updated: 10:16 AM EDT, Jul 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lexicon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

A Preview Of Lexicon Pharmaceuticals's Earnings ↗

May 12, 2025

Via Benzinga

Top 2 Health Care Stocks That May Crash This Month ↗

April 25, 2025

Via Benzinga

Curious about the most active stocks on Monday? ↗

March 31, 2025

Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.

Via Chartmill

US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst ↗

March 31, 2025

U.S. stock futures fell on Monday after three consecutive days of decline on Friday. Futures of benchmark indices were lower in premarket.

Via Benzinga

What Analysts Are Saying About Lexicon Pharmaceuticals Stock ↗

March 07, 2025

Via Benzinga

Lexicon Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

January 29, 2025

Via Benzinga

While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60% ↗

March 31, 2025

As uncertainties surrounding trade policies, fresh recession fears, and persistent inflation kept the markets on tenterhooks throughout the past week, a handful of small-caps defied the odds by posting...

Via Benzinga

Topics Economy

Emerging Tech Quartet – PRSO, LXRX, PRTG, RNAZ – Drive Breakthroughs Across Defense, Obesity, Oncology, and RNA Therapeutics

March 28, 2025

Via AB Newswire

Topics Intellectual Property

Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session. ↗

March 28, 2025

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Friday's session: most active stocks ↗

March 28, 2025

Curious about the most active stocks on Friday? Find out which stocks are dominating the market action!

Via Chartmill

Top movers in Friday's session ↗

March 28, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

What 6 Analyst Ratings Have To Say About Lexicon Pharmaceuticals ↗

March 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 28, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Friday's session. ↗

March 28, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Top movers in Friday's pre-market session ↗

March 28, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1 ↗

March 28, 2025

The company is looking for drugs it can add to Wegovy to improve the amount of weight lost.

Via Investor's Business Daily

Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected ↗

March 28, 2025

Via Benzinga

Topics Economy

Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk ↗

March 28, 2025

Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential milestone payments of up to $1 billion.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 28, 2025

Via Benzinga

Here are the top movers in Monday's session. ↗

March 03, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

March 03, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are gapping on Monday? ↗

March 03, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Lexicon Pharmaceuticals (LXRX) Stock Is Down: What's Going On? ↗

March 03, 2025

Lexicon Pharmaceuticals shares are trading lower by 48% Monday morning. The company earlier announced topline results from its PROGRESS Phase 2b study evaluating pilavapadin.

Via Benzinga

Monday's pre-market session: top gainers and losers ↗

March 03, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagliflozin to Reduce Major Adverse Cardiovascular Events (MACE)

February 18, 2025

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain

January 21, 2025

Event will feature insights on LX9211, Lexicon’s novel, investigational, non-opioid treatment, as well as expert panel and Q&A session on DPNP

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

Lexicon Appoints Scott Coiante as Chief Financial Officer

January 02, 2025

From Lexicon Pharmaceuticals, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.